BriaCell Therapeutics Corp. Warrant
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCTXZ research report →
Price Chart
About the company
BriaCell Therapeutics Corp. , a biotechnology company based in West Vancouver, Canada, is intensely focused on immuno-oncology, dedicated to engineering novel immunotherapies for cancer treatment. Its flagship compound, Bria-IMT, is a whole-cell cancer vaccine presently in Phase I/IIa clinical development, where it's being evaluated in conjunction with the investigational immunotherapy retifanlimab.
- CEO
- William V. Williams
- IPO
- 2025
- Employees
- 16
- HQ
- West Vancouver, BC, CA
Get TickerSpark's AI analysis on BCTXZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $527.45K
- P/E
- -0.33
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 1.22
- EV/EBITDA
- -0.90
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -147.92%
- ROIC
- -136.31%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-107,930+0.0%
- Op Income
- $-27,537,455
- Net Income
- $-26,633,600-455.9%
- EPS
- $-62.95-44.1%
- OCF Growth
- -18.2%
- FCF Growth
- -16.0%
- 52W High
- $0.47
- 52W Low
- $0.06
- 50D MA
- $0.14
- 200D MA
- $0.14
- Beta
- 1.54
- RSI (14)
- 61
- Avg Volume
- 117.72K
No earnings-call transcripts are available for BCTXZ yet.
- Free Float
- 88.4%
- Shares Outstanding
- 1.88M
- Float Shares
- 1.67M
Our BCTXZ coverage
Recent articles, reports, and earnings notes.
No research on BCTXZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCTXZ report →